The TOPPIC Trial: a randomised, double-blind parallel-group trial of mercaptopurine versus placebo to prevent recurrence of Crohn’s disease following surgical resection in 240 patients

Ian Dr Arnott, Craig Mowat, Holly Ennis, Catriona Keerie, Stephanie Lewis, Nicholas Kennedy, Aidan Cahill, Jack Satsangi

Research output: Contribution to conferencePaper

Fingerprint

Dive into the research topics of 'The TOPPIC Trial: a randomised, double-blind parallel-group trial of mercaptopurine versus placebo to prevent recurrence of Crohn’s disease following surgical resection in 240 patients'. Together they form a unique fingerprint.

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Biochemistry, Genetics and Molecular Biology